The National Cancer Institute is exploring a new new tech-based treatment to help patients overcome a severe breathing disorder caused by the Human Papilloma Virus.

Leaders from the agency's Center for Cancer Research — Dr. Clint Allen, a senior investigator, and Dr. Scott Norberg, an associate research physician — join us to discuss the findings from their recent study on the Recurrent Respiratory Papillomatosis, which can cause damage to the vocal cords and block airways, making it hard to breathe.

Allen and Norberg shared details about the therapy, which uses a gorilla adenovirus based-technology to target the infection.